دورية أكاديمية

Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12)

التفاصيل البيبلوغرافية
العنوان: Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12)
المؤلفون: Sunami, KazutakaAff1, Matsumoto, Morio, Fuchida, Shin-ichi, Omoto, Eijiro, Takamatsu, Hiroyuki, Adachi, Yoko, Choi, Ilsong, Fujishima, Naohito, Kiguchi, Toru, Miyamoto, Toshihiro, Maeda, Akio, Suzumiya, Junji, Yamamura, Ryosuke, Nagafuji, Koji, Nakazato, Tomonori, Kuroda, Yoshiaki, Yujiri, Toshiaki, Takamatsu, Yasushi, Harada, Mine, Akashi, Koichi
المصدر: International Journal of Clinical Oncology. 24(8):966-975
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:13419625
14377772
DOI:10.1007/s10147-019-01436-8